Phaos Technology Holdings (Cayman) (POAS) Change in Accured Expenses (2025)
Phaos Technology Holdings (Cayman) (POAS) reported Change in Accured Expenses of $779971.0 for Q4 2025, up 43.99% quarter-over-quarter from $541678.0 in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Change in Accured Expenses (2025) Analysis & Trends
Phaos Technology Holdings (Cayman) has reported Change in Accured Expenses for 1 years, with the latest figure at $779971.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Accured Expenses changed N/A year-over-year to $779971.0; the trailing twelve-month figure through Oct 2025 stood at $779971.0 (changed N/A YoY), and the FY2025 full-year result was $541678.0, up 268.46% from the prior year.
- Change in Accured Expenses for Q4 2025 stood at $779971.0, up from $541678.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $779971.0 in Q4 2025, with the low at $541678.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Phaos Technology Holdings (Cayman) | 682,234.12 | 627,245.12 | - | 779,971.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 779,971.00 |
| Oct 31, 2025 | 779,971.00 |
| Apr 30, 2025 | 541,678.00 |
| Apr 30, 2025 | 541,678.00 |